Iyona Rajkomar, MBBS, CFA

Iyona Rajkomar, MBBS, CFA, is a prominent figure in the biotechnology sector, currently serving as the Managing Partner at Dawn Biopharma, a platform controlled by KKR since May 2023. Prior to her role at Dawn Biopharma, she was associated with Pontifax, a venture capital firm focused on life sciences. Rajkomar has a medical background, having trained as a physician, and is based in London.13

In addition to her role at Dawn Biopharma, Rajkomar has been appointed to the Board of Directors of Adcendo, where she aims to contribute to the development of innovative therapies.134 Her educational qualifications include a medical degree from St. George's University in London, and she holds the Chartered Financial Analyst (CFA) designation, which underscores her expertise in finance and investment within the healthcare sector.2